Catechol-O-methyltransferase and blood pressure in humans

Circulation

Volumn 106, Issue 4, 2002, Pages 460-465

  Jordan, Jens ^a   Lipp, Axel ^a   Tank, Jens ^a   Schröder, Christoph ^a   Stoffels, Mandy ^a   Franke, Gabriele ^a   Diedrich, Andre ^a   Arnold, Guy ^a   Goldstein, David S ^a   Sharma, Arya M ^a   Luft, Friedrich C ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Baroreflex; Multiple system atrophy; Nervous system, autonomic; Receptors, adrenergic; Shy Drager syndrome

Indexed keywords

CATECHOL METHYLTRANSFERASE; CATECHOL METHYLTRANSFERASE INHIBITOR; ENTACAPONE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; TRIMETAPHAN; YOHIMBINE;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG RESPONSE; FEMALE; GANGLION BLOCK; HUMAN; MALE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SHY DRAGER SYNDROME; SYSTOLIC BLOOD PRESSURE;

BAROREFLEX; BLOOD PRESSURE; CATECHOL O-METHYLTRANSFERASE; CATECHOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; GANGLIONIC BLOCKERS; HUMANS; KINETICS; MALE; MIDDLE AGED; NITROPRUSSIDE; PHENYLEPHRINE; SHY-DRAGER SYNDROME; SYMPATHOMIMETICS; TRIMETHAPHAN; YOHIMBINE;

EID: 0037162386     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000022844.50161.3B     Document Type: Article

References (34)

1. Overflow of catecholamine neurotransmitters to the circulation: Source, fate, and functions
2. Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans
3. Catecholamine metabolism: From molecular understanding to clinical diagnosis and treatment
4. Genetic polymorphism of catechol-O-methyltransferase (COMT): Correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in Finland
5. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders
6. COMT inhibition by high-dose entacapone does not affect hemodynamics but changes catecholamine metabolism in healthy volunteers at rest and during exercise
7. Simultaneous inhibition of catechol-O-methyltransferase and monoamine oxidase A: Effects on hemodynamics and catecholamine metabolism in healthy volunteers
8. The effect of catechol-O-methyltransferase inhibition with entacapone on cardiovascular autonomic responses in L-Dopa-treated patients with Parkinson's disease
9. The effects of the COMT inhibitor entacapone on haemodynamics and peripheral catecholamine metabolism during exercise
10. Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure
11. Sympathetically mediated hypertension in autonomic failure
12. Sympathetic cardioneuropathy in dysautonomias
13. Contrasting actions of pressor agents in severe autonomic failure
14. Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure
15. Entacapone: A review of its use in Parkinson's disease
16. The definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy
17. The pressor response to water drinking in humans: A sympathetic reflex?
18. Use of alpha 2 adrenoreceptor agonists and antagonists in the functional assessment of the sympathetic nervous system
19. Pharmacology. Assessment of autonomic function
20. Patterns of plasma levels of catechols in neurogenic orthostatic hypotension
21. Severely impaired baroreflexbuffering in patients with monogenic hypertension and neurovascular contact
22. Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease
23. N-cholinergic blockade in dissecting the components of cardiovascular regulation
24. N-nicotinic blockade as an acute human model of autonomic failure
25. Aging and cardiovascular responsiveness to beta-agonist in humans: Role of changes in beta-receptor responses versus baroreflex activity
26. Malignant vagotonia due to selective baroreflex failure
27. Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure
28. Effects of various ganglionic blocking agents on blood pressure and on activity of pressor agents
29. Buffer reflexes, tolerance to ganglioplegics and their relationship to enhanced pressor responsiveness
30. Baroreflex buffering and susceptibility to vasoactive drugs
31. 2-adrenoreceptor responsiveness in autonomic dysfunction
32. Reference values of indices of spontaneous baroreceptor reflex sensitivity
33. Pharmacological distinction of different orthostatic hypotension syndromes
34. The effect of entacapone on the disposition and hemodynamic effects of intravenous isoproterenol and epinephrine